Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Don’t Blame Canada
Robert Goldberg, Ph.D., National Review Online, 12-23-04

Manhattan Institute senior fellow Robert Goldberg weighs in on the recently released HHS Task Force report on drug importation and describes it as “a welcome breath of fresh air in the increasingly stale debate over drug importation.”

While advocates of importation will undoubtedly spin the report into a moral victory, Goldberg focuses on the report’s central findings: “The fact is, there is only a limited amount of drugs that can be supplied at price-controlled levels worldwide. No degree of safety and surveillance can change the laws of supply and demand. Europeans and Canadians are able to get quality drugs at lower prices only because Americans pay free-market prices that fuel research and development.”

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000